EUVIMEDEUVIMED entdecken
Open Access

Neurological Toxicity in Metastatic Colorectal Cancer Patients Treated with Modified FOLFOX6 plus Bevacizumab

Satoshi Otsu, Yoshinori Hirashima, Kazuo Nishikawa, Hiroyuki Sakashita, Ryotaro Morinaga, Koichiro Watanabe, Kuniaki Shirao

Japanese Clinical Medicine · 2014

DOI: 10.4137/jcm.s15553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Japanese Clinical Medicine, 2014. Verfasst von Satoshi Otsu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology and Hematology, Oita University, Faculty of Medicine, Oita, Japan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study was conducted to investigate the toxicity and efficacy of modified FOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer with particular regard to oxaliplatin-induced neuropathy. Toxicity was graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) (version 3.0). The evaluation was especially focused on grade 2 oxaliplatin-induced neuropathy. The estimated median treatment time to occurrence of grade 2 sensory neuropathy was 7.3 months. The estimated median cumulative dose to occurrence of grade 2 sensory neuropathy was 931 mg/m 2 . This study clarified the treatment time from first dose as well as the cumulative dose of oxaliplatin leading to grade 2 neuropathy. It may be important to institute some clinical countermeasures when grade 2 neuropathy occurs so as to reduce the chance of progression to irreversible grade 3 neuropathy.

Schlagwörter

Stichwörter der Autor:innen

colorectal cancermodified FOLFOX6neuropathyoxaliplatin

Autor:innen und Institutionen

  • Department of Medical Oncology and Hematology, Oita University, Faculty of Medicine, Oita, Japan.
  • Department of Integrated Pulmonology, Tokyo Medical and Dental University, Tokyo, Japan.

Zitieren

APA

Otsu, S., Hirashima, Y., Nishikawa, K., Sakashita, H., Morinaga, R., Watanabe, K., & Shirao, K. (2014). Neurological Toxicity in Metastatic Colorectal Cancer Patients Treated with Modified FOLFOX6 plus Bevacizumab. Japanese Clinical Medicine. https://doi.org/10.4137/jcm.s15553

Vancouver

Otsu S, Hirashima Y, Nishikawa K, Sakashita H, Morinaga R, Watanabe K, et al. Neurological Toxicity in Metastatic Colorectal Cancer Patients Treated with Modified FOLFOX6 plus Bevacizumab. Japanese Clinical Medicine. 2014. doi:10.4137/jcm.s15553

BibTeX
@article{Otsu2014,
  author = {Otsu, Satoshi and Hirashima, Yoshinori and Nishikawa, Kazuo and Sakashita, Hiroyuki and Morinaga, Ryotaro and Watanabe, Koichiro and Shirao, Kuniaki},
  title = {Neurological Toxicity in Metastatic Colorectal Cancer Patients Treated with Modified FOLFOX6 plus Bevacizumab},
  journal = {Japanese Clinical Medicine},
  year = {2014},
  doi = {10.4137/jcm.s15553}
}
Kostenlos starten →